TD Cowen raised the firm’s price target on Enhabit (EHAB) to $9 from $8 and keeps a Hold rating on the shares. The firm updated its model following Q4 results and raised estimates given anticipated performance in the Hospice division.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHAB:
- Enhabit, Inc: Hold Rating Amid Mixed Segment Performance and Growth Challenges
- Enhabit, Inc. Reports Q4 Results and 2025 Outlook
- Enhabit, Inc. Navigates Growth Amid Challenges
- Enhabit, Inc: Buy Rating Affirmed Amid Growth Potential and Stabilizing Fundamentals
- Enhabit selloff after Q4 report ‘unwarranted,’ says Jefferies